PEPG CIK: 1835597

PepGen Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
140
FY22:
186
FY23:
113
FY24:
124
FY25:
151
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.66
FY22:
31.4
FY23:
30.4
FY24:
27.1
FY25:
22.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
144
FY22:
217
FY23:
143
FY24:
151
FY25:
174

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
10.3
FY22:
18.8
FY23:
17.5
FY24:
16.7
FY25:
12.6
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.23
FY22:
19.0
FY23:
17.1
FY24:
15.6
FY25:
13.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.1
FY22:
180
FY23:
108
FY24:
119
FY25:
147
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
217
FY23:
143
FY24:
151
FY25:
174

All amounts in millions USD Data source:SEC EDGAR